Kyntra Bio, Inc. Common Stock (KYNB) — Analysis Summary
Kyntra Bio, Inc. Common Stock (KYNB) has a market cap of $24.78M with year-over-year revenue growth of -78.3%. Net margin stands at 2848.6%. The stock trades at a P/E ratio of 0.1.
Key Takeaways
- Revenue changed -78.3% year-over-year
- Net margin of 2848.6%
- P/E ratio of 0.1
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, KYNB posted revenue growth of -78.3% and trades at a P/E of 0.1.
Kyntra Bio, Inc. Common Stock (KYNB)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -5.4x — earnings do not cover interest payments
Operating margin at -1090.0% — severe operating losses
Revenue fell 28.3% vs the prior period.
Shareholder equity is negative, which can signal balance-sheet stress.
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
Sector
PHARMACEUTICAL PREPARATIONS
Employees
34
Headquarters
SAN FRANCISCO, CA
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.